Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

UFS casts its net wider for collaborative partner engagement
2015-10-19

Ms Felicia Mabuza-Suttle and Mr Ndaba Ntsele

The office of Institutional Advancement at the University of the Free State hosted an event on 9 October 2015 in Johannesburg, to engage prospective partners and donors, to showcase its various projects and programmes, and to recognise existing donors for their contributions.

The event, titled “Revenge of the Caterpillar”, prompted a discussion on the story of change at the University of the Free State, focusing on transformation as well as new ways of advancing a University amidst recent events.

The programme director, Mr Ndaba Ntsele, CEO and Director of Pamodzi Holdings and member of the UFS Council, introduced the Vice-Chancellor and Rector, Prof Jonathan Jansen, to the audience. Mr Ntsele expressed his deep respect and confidence in the Vice-Chancellor and his leadership of the university.

Professor Jansen launched his new book, Leading for Change: Race, intimacy, and leadership on divided university campuses, which offers theoretical grounds for thinking about, and transforming, leadership and higher education worldwide. In the context of his book, Prof Jansen discussed inter-racial relationships among students at the UFS and their experiences, which mirror race relations in the country among communities that have come out of a long history of oppression, such as slavery and apartheid.

Prof Jansen also spoke of the challenges that have surfaced nationally on racial symbols on university campuses. “At the UFS, we have dealt with issues concerning racial symbolism.  It is important to lead in times of peace, in order to be able to lead in times of trouble,” he said.

A robust discussion followed, on the way forward for transformation at institutions of higher education, and how this affects communities and the nation at large.   The event was attended by representatives of donor and affiliate organisations of the UFS, such the Nedbank Group, The South African Holocaust and Genocide Foundation, and celebrity guests such as Gareth Cliff, Felicia Mabuza-Suttle and Leanne Manas.



We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept